R. Abi-Habib

发表

Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cells.

M. Willingham, S. Leppla, A. Frankel, 2004, Molecular cancer therapeutics.

Systemic Anthrax Lethal Toxin Therapy Produces Regressions of Subcutaneous Human Melanoma Tumors in Athymic Nude Mice

B. Berghuis, S. Leppla, A. Frankel, 2006, Clinical Cancer Research.

BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin

S. Leppla, A. Frankel, N. Duesbery, 2005, Molecular Cancer Therapeutics.

Recombinant anthrax lethal toxin inhibits cell motility and invasion in breast cancer cells through the dysregulation of Rho GTPases.

M. El-Sibai, R. Abi-Habib, D. El-Chami, 2020, Oncology letters.

Cytotoxicity modulation of ruthenium(II) tris-bathophenanthroline complexes with systematically varied charge

Rony S. Khnayzer, M. El-Sibai, H. Audi, 2018 .

Phototoxicity of strained Ru(ii) complexes: is it the metal complex or the dissociating ligand?

Rony S. Khnayzer, M. El-Sibai, H. Audi, 2017, Dalton transactions.

A urokinase-activated recombinant anthrax toxin is selectively cytotoxic to many human tumor cell types

S. Leppla, A. Frankel, T. Bugge, 2006, Molecular Cancer Therapeutics.

Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

S. Denmeade, B. Egerdie, R. Merchant, 2011, European urology.

Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity

Simon A. Williams, J. Browning, A. Frankel, 2007, Anti-cancer drugs.

Hippocampal Programmed Cell Death after Status Epilepticus: Evidence for NMDA‐Receptor and Ceramide‐Mediated Mechanisms

G. Dbaibo, M. Mikati, R. Abi-Habib, 2003, Epilepsia.

Wild carrot oil extract is selectively cytotoxic to human acute myeloid leukemia cells.

C. Daher, A. Bekdash, R. Abi-Habib, 2015, Asian Pacific journal of cancer prevention : APJCP.

3D modeling in cancer studies

M. El-Sibai, Massoud Vosough, Z. Farzaneh, 2021, Human Cell.

3D modeling in cancer studies

M. El-Sibai, Massoud Vosough, Z. Farzaneh, 2021, Human Cell.

Cytotoxicity of anthrax lethal toxin to human acute myeloid leukemia cells is nonapoptotic and dependent on extracellular signal-regulated kinase 1/2 activity.

S. Leppla, Elias Kassab, A. Frankel, 2013, Translational oncology.

Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review

M. El-Sibai, R. Abi-Habib, Houssam Al-Koussa, 2020, Cancer Cell International.

Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion.

Mirvat El-Sibai, Bechara Saykali, Shihui Liu, 2016, International journal of oncology.

Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent

M. El-Sibai, R. Abi-Habib, Ghenwa Nasreddine, 2019, Investigational New Drugs.

Human Recombinant Arginase I [HuArgI(Co)-PEG5000]–Induced Arginine Depletion Inhibits Pancreatic Cancer Cell Migration and Invasion Through Autophagy

M. El-Sibai, R. Abi-Habib, Isabelle Fakhoury, 2021, Pancreas.

Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA

M. El-Sibai, R. Abi-Habib, Isabelle Fakhoury, 2021, Journal of Ovarian Research.

Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF)1

S. Leppla, Elias Kassab, A. Frankel, 2015, Translational oncology.

Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells

M. El-Sibai, E. Stone, A. Frankel, 2015, Journal of Neuro-Oncology.

selectively cytotoxic to human acute myeloid leukemia blasts granulocyte-macrophage colony-stimulating factor receptor is A urokinase-activated recombinant diphtheria toxin targeting the

A. Frankel, T. Bugge, Stephen H. Leppla, 2009 .

A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts.

S. Leppla, A. Frankel, T. Bugge, 2004, Blood.

Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review

M. El-Sibai, R. Abi-Habib, Houssam Al-Koussa, 2020, Cancer Cell International.

Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.

G. Georgiou, Elias Kassab, E. Stone, 2013, Leukemia research.

Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion

M. El-Sibai, R. Abi-Habib, Houssam Al-Koussa, 2019, International journal of molecular sciences.

Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells

M. El-Sibai, M. Swayden, A. Bekdash, 2020, Human Cell.

[HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells

R. Abi-Habib, N. Khalil, 2019, Investigational New Drugs.

Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review).

M. El-Sibai, R. Abi-Habib, Isabelle Fakhoury, 2022, International journal of oncology.

Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.

G. Georgiou, Elias Kassab, E. Stone, 2013, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent

M. El-Sibai, R. Abi-Habib, Ghenwa Nasreddine, 2019, Investigational New Drugs.

Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

S. Denmeade, B. Egerdie, R. Merchant, 2011, European urology.